ReviewThe American journal of gastroenterology2015
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease.
Review in The American journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 25 citations in OpenAlex.
- Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.BMJ open gastroenterology · 2025Article
- Treat to target in Crohn's disease: A practical guide for clinicians.World journal of gastroenterology · 2024Review
- Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review.Crohn's & colitis 360 · 2023Article
- Treatment goals in IBD: A perspective from patients and their partners.PEC innovation · 2022Article
- Notable gaps between patients' and physicians' perspectives on communication and disease management in Japan: multifacetedTherapeutic advances in gastroenterology · 2022Article
- Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View.Inflammatory bowel diseases · 2021Article
- Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views.JGH open : an open access journal of gastroenterology and hepatology · 2021Article
- Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians.Inflammatory bowel diseases · 2021Article
- Standardizing Healthcare Delivery to Reduce Utilization, the Potential of Evidence-Based Care Pathways.Crohn's & colitis 360 · 2020Article
- Patient and physician preferences for ulcerative colitis treatments in the United States.Clinical and experimental gastroenterology · 2019Article
- Implementing a self-management strategy in inflammatory bowel disease (IBD): patient perceptions, clinical outcomes and the impact on service.Frontline gastroenterology · 2017Article
- How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study.BMC medical ethics · 2017Article
- Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.Inflammatory bowel diseases · 2017Article
- Factors Predicting the Adherence to the Therapy of Italian IBD Patients.Gastroenterology research and practice · 2017Article
- JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4Frontiers in immunology · 2017Article
- When Should Therapy for Inflammatory Bowel Disease Be Stopped?Gastroenterology & hepatology · 2015Article
- The ulcerative colitis narrative Greece survey: patients' and physicians' perspective on quality of life and disease management.Annals of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The doctor-patient relationship (DPR) in inflammatory bowel disease (IBD) has been facing new challenges, in part due to the substantial progress in medical and surgical management and also due to the rapid expansion of patient access to medical information. Not surprisingly, the complexity of IBD care and heterogeneity of the disease types may lead to conflict between a physician's therapeutic recommendations and the patient's wishes. In this commentary, we propose that the so-called "treat-to-target" approach of objective targets of disease control and serial adjustments to therapies can also strengthen the DPR in IBD by enabling defined trials of alternative approaches, followed by a more objective assessment and reconsideration of treatments. We contend that such respect for patient autonomy and the use of objective markers of disease activity improves the DPR by fostering trust and both engaging and empowering patients and physicians with the information necessary to make shared decisions about therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.